Patent · US Active

Pseudotyped viral particles, compositions comprising the same, and uses thereof

US12398377B2 · kind B2 · utility

0Cited by

18References

20Claims

0Family size

Assignee

Interius Biotherapeutics, Inc. · US

Inventors

Ronnie M. Russell · Philadelphia, US
Philip R. Johnson · Lansdowne, US
Bruce C. Schnepp · Havertown, US

Key dates

Filing date	Jan 31, 2025
Grant date	Aug 26, 2025
Priority date	—
Expiry date	Jan 31, 2045

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N7/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided for herein are mutant VSV-G polypeptides, compositions comprising the same, and methods of using the same. Also provided for herein are polypeptides and compositions that bind to CD7 and uses thereof. Also provided for herein are polypeptides and compositions that bind to CD8 and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.